LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.

about

Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes - a 10-year follow-up: Tehran Lipid and Glucose Study.Characterization and cholesterol management in patients with cardiovascular events and/or type 2 diabetes in the Netherlands.

P2860

Q51290661-AE61FE16-878C-4DB7-80A7-C6F14F9DFD1D Q51487624-771294C2-F882-47F6-B4AF-8B211933AC36

P2860

LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.

Item

http://www.wikidata.org/entity/Q41188538

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.

@en

type

Item

label

LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.

@en

prefLabel

LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.

@en

P1476

LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.

@en

P2093

A-M Svensson

http://www.w3.org/2001/XMLSchema#string

C Hero

http://www.w3.org/2001/XMLSchema#string

K Eeg-Olofsson

http://www.w3.org/2001/XMLSchema#string

P Gidlund

http://www.w3.org/2001/XMLSchema#string

S Gudbjörnsdottir

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Standards of medical care in diabetes--2014

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study.

LDL-cholesterol, HDL-cholesterol or triglycerides--which is the culprit?

Predicting major outcomes in type 1 diabetes: a model development and validation study

The validity of a diagnosis of heart failure in a hospital discharge register.

P304

316-323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DME.13007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bjorn Eliasson

P577

2015-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26498834

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.

about

P2860

P2860

LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921